Correlation Engine 2.0
Clear Search sequence regions


  • acid (2)
  • autism (5)
  • gaba (1)
  • gaba modulators (3)
  • human (2)
  • pathogenesis (1)
  • Sizes of these terms reflect their relevance to your search.

    Autism spectrum disorders are an emerging health problem worldwide, but little is known about their pathogenesis. It has been hypothesized that autism may result from an imbalance between excitatory glutamatergic and inhibitory GABAergic pathways. Commonly used medications such as valproate, acamprosate, and arbaclofen may act on the GABAergic system and be a potential treatment for people with ASD. The present systematic review aimed at evaluating the state-of-the-art of clinical trials of GABA modulators in autism. To date there is insufficient evidence to suggest the use of these drugs in autistic subjects, even if data are promising. Of note, short-term use of all the reviewed medications appears to be safe. Future well designed trials are needed to elucidate these preliminary findings.

    Citation

    Natascia Brondino, Laura Fusar-Poli, Cristina Panisi, Stefano Damiani, Francesco Barale, Pierluigi Politi. Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies. Journal of autism and developmental disorders. 2016 Mar;46(3):825-39

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 26443675

    View Full Text